Here are relevant reports on : artificial-intelligence-drug-discovery-market
-
Europe Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The Europe AI market size was estimated at USD 86.24 billion in 2025 and is projected to reach USD 548.03 billion by 2032, growing at a CAGR of 30.2% from 2025 to 2032. The major players in the Europe AI market include SAP (Germany), Microsoft (US), IBM (US), Oracle (US), AWS (US), Siemens (Germany), NVIDIA (US), OpenAI (US), Google (US), H2O.ai (US), and Salesforce (US), along with startups/SMEs such as Graphcore (UK), DeepL (Germany), Synthesia (UK), and Gamaya (Switzerland).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
India Artificial Intelligence in Manufacturing Market By Processor (MPUS, GPUs, FPGA, ASICs), Software (On-premises, Cloud), Technology (Machine Learning, NLP, Context-aware Computing, Computer Vision, Generative AI), Application - Forecast to 2030
The market size for India AI in manufacturing is estimated to reach USD 860.5 million in 2025 and is projected to grow to approximately USD 4,889.7 million by 2030, at a CAGR of 41.5%. The key players include NVIDIA Corporation (US), IBM (US), Google (US), Microsoft (US), Intel Corporation (US), Siemens (Germany), GE Vernova (US), Honeywell International Inc. (US), Mitsubishi Electric Corporation (Japan), and UBTECH ROBOTICS CORP LTD (China). Indian-specific startups shaping the landscape include Neuralzome Cybernetic, Perceptyne Robots, and atimotors.com.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Industrial Artificial Intelligence Market by Offering (Hardware, Software), Technology (Deep Learning, Computer Vision, Context Awareness, and Natural Language Processing), Application, Industry, and Geography - Global Forecast to 2023
The industrial Artificial Intelligence (AI) market is witnessing significant growth because of the extensive usage of big data, industrial robots, and Internet of Things (IoT). AI-based solutions are adopted in manufacturing facilities to improve the productivity by maximizing asset utilization, minimizing downtime, and improving machine efficiency. Moreover, industrial AI is expected to enhance productivity through quality control by detecting defects and help in the predictive maintenance of factory machinery. The Industrial AI market was valued at USD 272.5 Million in 2016 and is expected to reach USD 4,882.9 Million by 2023, growing at a CAGR of 52.42% between 2017 and 2023.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
US Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The US artificial intelligence market size is projected to reach USD 750.04 billion by 2032. The key players include Microsoft (US), IBM (US), Google (US), AWS (US), NVIDIA (US), Oracle (US), and Scale AI (US), along with startups such as Anthropic (US), Cerebras (US), OpenAI (US), and Anduril Industries (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030
The global quantum computing in healthcare market, valued at US$191.3 million in 2024, stood at US$265.9 million in 2025 and is projected to advance at a resilient CAGR of 37.9% from 2025 to 2030, culminating in a forecasted valuation of US$1324.2 million by the end of the period. The quantum computing in healthcare market is rapidly growing, driven by the need for faster and more advanced data analysis in areas like drug discovery, genomics, and precision medicine.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Tissue Banking Market by Product (Equipment, Consumables, Media, Accessories), Services (Tissue Retrieval, Processing), Application (Drug Discovery, Therapeutic) - Global Trends & Forecast to 2019
Tissue banks facilitate the collection and banking of freshly-frozen tissue specimens. These tissues play a vital role in research into diseases and disorders, and general healthcare. They can be used to repair damaged heart muscles post-heart attacks, in skin replacement for burn victims, and in the treatment of spinal cord injuries, among other significant applications. The advancement of clinical trials and biomedical research in organ transplantation has created many prospects for tissue preservation and banking.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The South Korea next-generation sequencing market, valued at USD 0.19 billion in 2025, stood at USD 0.20 billion in 2026 and is projected to advance at a resilient CAGR of 14.0% from 2026 to 2031, culminating in a forecasted valuation of USD 0.39 billion by the end of the period. The report profiles key players such as Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), PacBio (US), and Oxford Nanopore Technologies plc. (UK).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The Europe Next-generation Sequencing Market, valued at US$4.11 billion in 2024, stood at US$4.42 billion in 2025 and is projected to advance at a resilient CAGR of 15.0% from 2025 to 2030, culminating in a forecasted valuation of US$8.88 billion by the end of the period. The Europe next-generation sequencing market is expanding on the back of accelerating use of sequencing across oncology, rare disease diagnostics, and broader precision medicine programs, supported by robust public and private research funding
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Chromatography Resin Market in Drug Discovery by Type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), and Region - Global Forecast to 2022
MarketsandMarkets projects that the market for chromatography resin in drug discovery will grow from USD 290.7 Million in 2017 to USD 401.1 Million by 2022, at a CAGR of 6.65% from 2017 to 2022. The growth of this market is expected to be driven by the rising demand from pharmaceuticals and biotechnology verticals. Companies such as General Electric Company (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Tosoh Corporation (Japan) were the key players who adopted these strategies to increase their customer base and widen their product portfolio.
- Published: June 2017
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
